NDATOPICALAEROSOL, FOAM
Approved
Oct 2015
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Mechanism of Action
D3 analog and betamethasone dipropionate as a synthetic corticosteroid. However, while their pharmacologic and clinical effects are known, the exact mechanisms of their actions in the treatment of plaque psoriasis are unknown.
Indications (1)
Clinical Trials (2)
Taltz in Combination With Enstilar for Psoriasis
Started Apr 2020
25 enrolled
Psoriasis
Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis
Started Jul 2018
50 enrolled
Psoriasis
Loss of Exclusivity
LOE Date
Dec 10, 2031
70 months away
Patent Expiry
Dec 10, 2031
Company
Leo Pharma
Denmark - Ballerup